Gregory Mossinghoff is listed as an executive officer on 3 SEC Form D filings by 1 issuer between Feb 2015 and Jul 2016: G1 Therapeutics, Inc. (Research Triangle Park, NC — biotechnology — 2015–2016; $50M reported sold to 21 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Christy Shaffer (3 shared filings), Mark A. Velleca (3 shared filings), Ron Laufer (3 shared filings), Seth Rudnick (3 shared filings), Frederic N. Eshelman (2 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Gregory. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 1 court case matching the name listed in Key records below.
What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for Gregory Mossinghoff and found 3 differences: Bankruptcy case: Michael L. Gutch; Bankruptcy case: Michael C. Gutch and Maureen R. Gutch; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.